ABSTRACT -Repeated dose toxicity of 3-aminophenol was examined on oral administration to newborn and young rats, and susceptibility was analyzed in terms of the no observed adverse effect level (NOAEL) and the unequivocally toxic level. In the 18-day newborn rat study, starting at day 4 after birth, tremors and depression of body weight gain were observed, as well as hypertrophy of thyroid follicular epithelial cells and increases of relative liver and kidney weights at 240 mg/kg. Increase of relative liver weights in males and decrease of blood sugar in females without any histopathological changes at 80 mg/ kg were not considered to be adverse effects. No chemical-related changes were observed at 24 mg/kg. Abnormalities of external development and reflex ontogeny in the newborn were not observed. In the 28-day study, starting at 5 weeks of age, depression of body weight gain, tremors, anemia, and liver, kidney and thyroid toxicity were observed at 720 mg/kg. Although slight pigmentation in the renal proximal tubular epithelium was observed in females at 240 mg/kg, this was not considered to be an adverse effect because of the lack of changes in related toxicological parameters. It was concluded that the NOAEL is 80 mg/kg/day in newborn rats and 240 mg/kg/day in young rats, with unequivocally toxic levels of 240 mg/kg/day and 720 mg/kg/day, respectively. Based on these two endpoints, the susceptibility of newborn rats to the chemical was approx. 3 times higher than that of young rats, consistent with our previous results for 4-nitrophenol and 2,4-dinitrophenol.
INTRODUCTION
The toxicity of chemicals is generally evaluated on the basis of results of repeated dose, developmental and reproductive toxicity studies in adult animals. While unique and/or higher toxicity of some chemicals in infants has recently been reported (Lee, 1998; Khan et al., 1998; Katsuda et al., 2000) , there is no systematic toxicity study protocol to examine direct toxic effects of chemicals in newborn animals. Although the results of one-and/or two-generation studies might reflect the toxicity of chemicals in infants exposed from the neonatal period to weaning, the exposure occurs only via their maternal milk. As there is a significant possibility that infants are exposed to chemicals directly via mouthing toys and household materials, or having chemical-contaminated milk and baby food, and so on, we should examine toxicity levels and profiles of chemicals in infant animals by direct exposure.
For this purpose, we have established a protocol for infant repeated dose toxicity studies to allow comparison of results with those of the routine repeated dose toxicity study in young animals . We have already examined the toxicity of 14 phenolic chemicals in newborn rats using this protocol and reported comparative toxicity evaluation of two nitrophenols, 4-nitrophenol and 2,4-dinitrophenol (Koizumi et al., , 2002 Takano et al., 2001; Yamamoto et al., 2001) . Comparison of toxicity levels was especially focused on unequivocally toxic levels, defined as doses inducing severe toxic signs including death or critical histological damage, as well as no observed adverse effect levels (NOAELs), in both newborn and young rats. Integral analysis, including dosefinding studies, demonstrated the toxic susceptibility of newborn rats to these chemicals to be 2 to 4 times higher than that of young rats.
In this study, 3-aminophenol was chosen for analysis. This chemical has been widely used as a raw material for generation of heat-sensitive dyes and pesticides, with a production capacity of 1,500 tons in Japan in 2000, as stated in the Chemical Products' Handbook (2002) . An earlier feeding study using weanling female Sprague-Dawley rats, exposed for 90 days followed by mating without exposure and reexposure during their gestation period, demonstrated hemolytic anemia and morphological change in the thyroid glands at the highest dose, 1% in the diet, but no teratogenic or embryofetal toxicity was observed (Re et al., 1984) . Recently, a 28-day repeated dose study in young rats was conducted as part of the Japanese existing chemical safety program (MHLW, 2001) . As the latter was evaluated for no observed effect level (NOEL) and toxicity profile, we re-evaluated the same study for the NOAEL and the unequivocally toxic level to compare with those from a newborn study using the same strain of rats.
MATERIALS AND METHODS

Materials
3-Aminophenol (CAS No. 591-27-5, 99.7% purity) was obtained from Mitsui Chemicals Inc. (Tokyo, Japan) and suspended in 1.0 w/v% carboxymethylcellulose-Na (Maruishi Pharmaceutical Co., Ltd., Osaka, Japan) solution. The suspension was prepared at least once a week and the stability of 3-aminophenol under these conditions was confirmed to be at least 8 days. All other reagents used in this study were specific purity grade.
Animals
Sprague-Dawley SPF rats [Crj: CD(SD)IGS] were purchased from Charles River Japan Inc. (Atsugi, Japan) and maintained in an environmentally controlled room at 19~24°C with a relative humidity of 35 69%, a ventilation rate of 10~15 times per hr, and a 12:12 hr light/dark cycle. For the 18-day study of newborn rats, 20 pregnant rats (gestation day 14) were purchased and normally delivered. Among all newborn separated from each dam at the age of 3 days, 4 males and 4 females were randomly selected and assigned to 4 dose groups, including controls. Twelve foster mothers suckled the 4 males and 4 females assigned to each group up to weaning on day 21 after birth (termination of dosing). After weaning, the animals of the recoverymaintenance group were individually maintained for 9 weeks. In the 28-day study of young rats, 4 week-old male and female rats were obtained and used at ages of 5-week-old after a one-week acclimation. All animals were allowed free access to sterilized basal diet (CRF-1, Oriental Yeast Co. Ltd., Tokyo, Japan) and tap water.
Study design (Time schedule the same as reported previously (Koizumi et al., 2001)) 1. 18-Day repeated dose study in newborn rats 1) Dose-finding study Newborn rats (6/sex/dose) were administered the test substance at 0, 30, 80 or 240 mg/kg/day by gastric intubation from days 4 to 21 after birth. Rats were examined for general behavior, body weight and physical development (abdominal fur appearance, incisor eruption, eye opening) during the dosing period, and sacrificed at 22 days of age after overnight starvation for assessment of hematology (red blood cell count (RBC), hemoglobin (Hb), hematocrit (Ht), white blood cell count, platelet count), blood biochemistry (total protein, glucose, total cholesterol, urea nitrogen (BUN), glutamate oxaloacetate transaminase (GOT), glutamate pyruvate transaminase (GPT), alkaline phosphatase), macro findings and organ weights.
2) Main study
Newborn rats were administered the test substance at 0, 24, 80 or 240 mg/kg/day by gastric intubation daily from days 4 to 21 after birth, based on results of the dose-finding study, and sacrificed after overnight starvation following the last treatment (scheduled-sacrifice group). Recovery-maintenance groups at the same dosages were maintained for 9 weeks without chemical treatment and fully examined at 12 weeks of age. The number of animals at each sex/dose was 6 for both the scheduled-sacrifice and recovery-maintenance groups.
General behavior was observed daily for newborn rats and foster mothers. Body weights were mea-sured twice a week during the dosing period and once a week during the recovery-maintenance period. For food consumption, cumulative values for 2-4 days were measured during the recovery-maintenance period. Abdominal fur appearance was observed at ages of 7 and 11 days, incisor eruption at 11 and 14 days, eye opening at 14 and 17 days, preputial separation at 42 and 49 days, and vaginal opening at 35 and 42 days. At treatment day 18, the pupillary reflex, corneal reflex, surface righting, mid-air righting and auricular reflexes (Preyer reflexes) were examined as parameters of reflex ontogeny. Color, pH, occult blood, protein, glucose, ketone bodies, bilirubin, urobilinogen, urine sediment, osmotic pressure and urine volume were examined in the last week of the recoverymaintenance period. For hematology and blood biochemistry, blood was collected from the abdominal aorta under ether anesthesia at sacrifice after overnight starvation for both the scheduled-sacrifice and recovery-maintenance groups. One part of the blood was examined for hematological parameters such as RBC, Hb, Ht, mean corpuscular volume, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, white blood cell count, platelet count, reticulocyte ratio and differential leukocyte count. In addition, blood-clotting parameters such as prothrombin time and activated thromboplastin time were measured for the recovery-maintenance group. Plasma obtained from the other portion of the blood was analyzed for blood biochemistry (total protein, albumin, albuminglobulin ratio, glucose, total cholesterol, triglycerides, total bilirubin, BUN, creatinine, GOT, GPT, γ -glutamyl transpeptidase, lactate dehydrogenase, alkaline phosphatase, phospholipid, calcium, inorganic phosphorus, sodium, potassium, chlorine). After recording of macro findings for all organs of animals sacrificed under ether anesthesia, the brain, pituitary gland, heart, thymus, liver, kidneys, spleen, adrenals, thyroids, lungs, testes, epididymides, ovaries and uterus were removed and weighed. The trachea, pancreas, lymph node, esophagus, submandibular gland, sublingual gland, stomach, intestine, urinary bladder, eyeballs, spinal cord, sciatic nerve, seminal vesicles, prostates, vagina, mammary gland, bone and bone marrow, skeletal muscle, skin and macroscopic abnormal regions as well as the above organs were fixed with 10% buffered formalin-phosphate (following Bouin's fixation for testes and epididymis, and following 3% glutaraldehyde/2.5% formalin-fixation for eyeballs), and paraffin sections were routinely prepared and stained with hematoxylin-eosin for microscopic examination.
2. 28-Day repeated dose study in young rats 1) Dose-finding study (14-day study)
Five-week-old rats (5/sex/dose) were administered the test substance at 0, 80, 200 or 500 mg/kg/day by gastric intubation for 14 days. Rats were examined for general behavior, body weight and food consumption during dosing and sacrificed at day 15 after overnight starvation for assessment of hematology (RBC, Hb, Ht, mean corpuscular volume, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, white blood cell count, platelet count), blood biochemistry (total protein, glucose, total cholesterol, triglyceride, BUN, creatinine, GOT, GPT, alkaline phosphatase, sodium, potassium, chlorine), macro findings and organ weights.
Five-week-old rats were given the test substance by gastric intubation daily for 28 days and sacrificed after overnight starvation following the last treatment (scheduled-sacrifice group). Referring to the results of the above dose-finding study, 4 doses were established (0, 80, 240 or 720 mg/kg/day). Recovery groups (0 and 720 mg/kg/day) were maintained without chemical treatment for 2 weeks after the last treatment and fully examined at 11 weeks of age. The number of animals for each sex/dose was 7 for both the scheduled-sacrifice and recovery groups. Rats were examined for general behavior, body weight, food consumption, urinalysis, hematology, blood biochemistry, necropsy findings, organ weights and histopathological findings in compliance with the Test Guideline of the Japanese Chemical Control Act (Official Name: Law Concerning the Examination and Regulation of Manufacture, etc. of Chemical Substances) under Good Laboratory Practice conditions.
Statistical analysis
Continuous data were analyzed by the Bartlett's test (Bartlett, 1937) for homogeneity of distribution. When homogeneity was recognized, Dunnett's test (Dunnett, 1964) (p < 0.01 or 0.05) was conducted for comparison between control and individual treatment groups (after one-way layout analysis of variance (Yoshimura, 1997) for the 28-day young rat study). If not homogenous, the data were analyzed using the Kruskal-Wallis test (Kruskal and Wallis, 1952) following the Mann-Whitney's U test (Mann and Whitney, 1947 ) (p < 0.05) or a mean rank test of the Dunnett type (Hollander and Wolfe, 1973 ) (p < 0.01 or 0.05). For quantitative urinalysis data, the cumulative chi square test (Yoshimura, 1987) (p < 0.01 or 0.05) or the Kruskal-Wallis ranking test (Kruskal and Wallis, 1952) following the Mann-Whitney's U test (Mann and Whitney, 1947) (p < 0.05) was performed. In the newborn rat study, data for physical development and reflex ontogeny were analyzed by the chi square test (Fisher, 1922) and histopathological results by the Mann-Whitney's U test (Mann and Whitney, 1947) (p < 0.01 or 0.05).
RESULTS
18-Day study in newborn rats (including the dosefinding study)
No deaths occurred up to 240 mg/kg in either the dose-finding study or the main study. The toxicity profile, including effects on general behavior, body weight and organ weights, was the same in both cases. In the 240 mg/kg group in the main study, tremors were observed in all animals from dosing days 2 to 12 and then the incidence decreased, with disappearance after dosing day 16 in males and 17 in females. In this group, the body weights were significantly lowered from dosing day 8 in males and from dosing day 4 in females, as shown in Fig. 1 . The body weights of both sexes at 24 and 80 mg/kg were comparable to the control values. No definitive changes in abdominal fur appearance, incisor eruption, eye opening, preputial separation or vaginal opening, as well as reflex ontogeny parameters were detected in any of the dose groups.
At the scheduled sacrifice in the main study, hematological examination showed only a slight increase in the reticulocyte ratio in 240 mg/kg males (21.7%, compared to 18.0% in controls) but no changes in RBC, Hb and Ht in any groups. On blood chemical examination, total bilirubin was significantly increased in both sexes at 240 mg/kg group and slight lowering of glucose was noted in females at 80 and 240 mg/kg, as shown in Table 1 . There were no doserelated changes in GOT, GPT and BUN, major parameters for hepatic and renal toxicity. Significant increases in relative liver weight were found in both sexes at 240 mg/kg and males at 80 mg/kg (Table 2) . Although a very slight increase in relative kidney weights was also evident in females at 240 mg/kg, no changes were observed in thyroid gland and reproductive organ weights. On histopathological examination, slight hypertrophy of follicular cells in the thyroid glands was observed in 4/6 males and 2/6 females at 240 mg/kg. There were no dose-related changes in his- topathology of other organs, including the liver, kidneys and spleen. There were no chemical-related changes in the recovery-maintenance study except a slight increase in RBC (852×10 4 /µL, compared to 802×10 4 /µL in controls), Hb (16.3 g/dL, 15.5 g/dL) and Ht (49%, 46%) in 240 mg/kg females at the end of the period.
The NOAEL for newborn rats was concluded to be 80 mg/kg/day, although a slight increase in relative liver weight in males with no histopathological change and a slight low of blood glucose in females were found at this dose. The unequivocally toxic level was 240 mg/kg/day, based on clear toxic signs such as tremors, depression of body weight gain and histopathological change in thyroid glands.
28-Day study in young rats (including the dosefinding study)
No deaths occurred up to 500 mg/kg in the dosefinding study and 720 mg/kg in the main study. Tremors and salivation were observed only on the first dosing day in a few females of the 500 mg/kg group in the dose-finding study and sporadically during the dosing period in both sexes of the 720 mg/kg group in the main study (Table 3) . Body weights were comparable to control values at 500 mg/kg in the dose-finding study, but in the main study significant lowering from dosing day 2 to recovery day 7 was evident, but at most 10% in both sexes at 720 mg/kg. Food consumption was decreased transiently during the dosing period in both sexes at 720 mg/kg in the main study. Urinalysis at dosing week 4 revealed significant increases in urine volume and water consumption, with decrease in urine specific gravity only noted in females at 720 mg/kg in the main study.
At the scheduled sacrifice, anemia with decrease in RBC and Hb, and an increased reticulocyte ratio were observed in females receiving 720 mg/kg in the main study (Table 4) but not in the dose-finding study at any dose. Blood chemical examination showed a slight increase in GPT (26.0 IU/L, compared to 22.8 IU/L in controls) at 500 mg/kg in the dose-finding study, and increases in GPT and total bilirubin in both sexes, increase in total cholesterol and decrease in triglyceride in males, and increase in BUN in females at 720 mg/kg in the main study, as shown in Table 5 . There were significant increases in absolute or relative weights of thyroid glands and relative weights of liver and kidneys in both sexes, as well as absolute and relative spleen weights in females given 720 mg/kg (Table 6 ). On histopathological examination in the main study, slight to mild changes related to hemolytic action were observed in liver, kidneys and spleen in both sexes at 720 mg/kg, as shown in Table 7 . At 240 mg/kg, slight deposition of pigment in the renal proximal tubular epithelium was only observed in females. As for other changes, hypertrophy of thyroid follicular cells in both sexes and of basophilic cells in the pituitary glands in two of seven males was noted at 720 mg/kg. In kidneys, the incidence of hyaline droplets in proximal epithelium was increased in males at 720 mg/kg. In the recovery group (720 mg/kg), a significant decrease of RBC and Hb and increase of the reticulocyte ratio in males and increase of Ht in females were found (Table 4) . Deposition of hemosiderin in various tissues was greatly reduced, but still remained in the spleen of males and kidneys and spleen of females (Table 7) . Hypertrophy of follicular cells in thyroid glands had completely disappeared, although increased relative weights still remained. None of the other changes observed in the dosing period and at the scheduled sacrifice persisted in males and females of the recovery groups. (g) 6.0 ± 1.0 7.1 ± 1.5 6.6 ± 0.9 6.8 ± 1.6 (10.5 ± 2.2) (12.3 ± 3.4) (11.4 ± 2.0) (13. 6.6 ± 1.1 7.4 ± 0.8 7.4 ± 1.6 6.9 ± 0.4 (12.1 ± 2.1) (13.6 ± 1.3) (13.9 ± 2.7) (14.5 ± 1.7) Liver (g) 1.65 ± 0.15 1.65 ± 0.11 1.65 ± 0.20 1.59 ± 0.17 (2.99 ± 0.09) (3.01 ± 0.09) (3.10 ± 0.08) (3.30 ± 0.11**) Spleen (g) 0.27 ± 0.06 0.22 ± 0.03 0.21 ± 0.03* 0.17 ± 0.03** (0.50 ± 0.13) (0.40 ± 0.04) (0.40 ± 0.04) (0.35 ± 0.04*) Kidney (g) 0.63 ± 0.07 0.66 ± 0.04 0.65 ± 0.08 0.65 ± 0.08 (1.14 ± 0.07) (1.21 ± 0.04) (1.22 ± 0.04) (1.35 ± 0.10**) Ovary (mg) 11.5 ± 4.6 10.5 ± 2.4 8.8 ± 1.7 10.2 ± 2.1 (20.4 ± 7.3) (19.1 ± 3.7) (16.5 ± 2.3) (21.2 ± 3.8) Uterus (mg) 43 ± 4 44 ± 7 38 ± 6 37 ± 8 (79 ± 12) (80 ± 13) (72 ± 13) (77 ± 12) a) : Body weights after overnight starvation following the last dosing, b) : Absolute weights, c) : Relative weights (g or mg/100 g body weight). *: Significantly different from control group (p<0.05), **: Significantly different from control group (p<0.01).
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The NOAEL was concluded to be 240 mg/kg/ day, because slight pigmentation in the renal proximal tubular epithelium observed in females at this dose was not considered an adverse effect owing to no accompanying hematological changes. As for the unequivocally toxic level, 720 mg/kg/day is appropriate, based on anemia, hepatotoxicity and renal toxicity, in addition to tremors, depression of body weight gain and histopathological changes in thyroid glands.
DISCUSSION
Neonates exhibit many differences in characteristics compared to young adults. As physiological differences relative to the body weight of neonates, there is a greater % of body water and a lower % of body fat, greater cardiac output and respiratory rate, larger liver and brain, and higher blood flow to the brain but less to kidneys. Functional immaturities in neonates are found in phase I and phase II drug metabolic enzymes, renal function, and the blood-brain barrier. Furthermore, all organs of neonates develop quickly, especially in terms of increase in organ size and function, including the neuron network in the brain. Considering these differences, it might be expected that chemical toxicity in neonates may be higher or having a different profile. In our first comparative toxicity analysis of two chemicals, 4-nitrophenol and 2,4-dinitrophenol, the toxic Table 3 . Clinical signs in repeated dose studies of 3-aminophenol in young rats. Table 4 . Hematological findings for 28-day repeated dose study of 3-aminophenol in young rats (main study). 26.0 ± 5.0 27.1 ± 7.4 53.3 ± 19.6* 17.7 ± 3.9 17.9 ± 1.8 *: Significantly different from control group (p<0.05), **: Significantly different from control group (p<0.01).
response to these chemicals in newborn rats was at most 4 times higher than that in young rats, based on the NOAEL and the unequivocally toxic level . This latter was defined as a dose-inducing severe toxicity, including death or critical histopathological changes. In the previous analysis, it was estimated as dose-inducing death, because no other clear signs were observed. Although the definition of the unequivocally toxic level seems not uniform, it should be valuable if it is estimated according to appropriate toxicity endpoints. As the chemicals in question caused neither developmental toxicity nor morphological changes, the higher toxicity in newborn rats seems to be due to physiological and functional differences. In the first case, using both toxicity endpoints enables us to draw a more reliable conclusion of toxicity differences between newborn and young animals.
In this study, 3-aminophenol was selected for the second trial comparative toxicity analysis between newborn and young rats. The NOAELs were relatively simply concluded to be 80 mg/kg/day for newborn rats and 240 mg/kg/day for young rats. The unequivocally toxic levels for both were based on low body weights, tremors and histopathological changes in the thyroid glands, being 240 mg/kg/day for newborn rats and 720 mg/kg/day for young rats. These results indicate that the toxic sensitivity of newborn rats to 3-aminophenol is three times higher than that in young rats (NOAEL 240/80 = 3, unequivocally toxic level 720/240 = 3). As anemia, hepatotoxicity and renal toxicity appeared in young rats, but not in newborn rats (although slightly suggestive data were also obtained for the latter), all these changes might have been due to hemolytic toxicity. Although methemoglobin levels were not determined in this study, it is well known that aromatic amines induce methemoglobinemia, leading to hemolytic anemia. As 2-aminophenol, 4-aminophenol and phenylhydroxyamine induce methemoglobinemia at least in vitro, and the potency of phenylhydroxyamine is the highest (Harrison and Jollow, 1987; Akazawa et al., 2000) , hydroxylation of aminophenols in vivo might be a key point. If so, lower susceptibility regarding anemia than for other parameters of toxicity in the newborn might be due to the lower hepatic hydroxylation potential.
Only one toxicity study of 3-aminophenol has been reported to our knowledge, a 90-day female rat study at doses of 0.1, 0.25 and 1.0% in the diet (Re et al., 1984) . In the 0.25% group, a significant reduction in body weight was noted, and in the 1.0% group we observed significant reduction in body weights and deposition of iron-positive pigments in the spleen, liver, and kidney, combined with decreased RBC and Hb, indicating a hemolytic effect. There were also morphologic changes in the thyroid gland, consistent with hyperactivity. This observed toxicity is entirely in agreement with our 28-day study results, although the actual daily intake in the diet study was not given. A structural isomer, 4-aminophenol is a major metabolite of the analgesic and antipyretic drug, acetaminophen, and is known to exert renal toxicity (Green et al., 1969; Calder et al., 1979) . Mechanistic studies in rats suggest that 4-aminophenol may be oxidized to benzoquinoneimine and then conjugated with glutathione in the liver to be excreted in the bile, and subsequently reabsorbed and transported via the systemic circulation to the kidney, where toxic effects occur (Garland et al., 1990) . Relatively recent studies have also indicated a contribution of glutathione to renal toxicity in rats and mice (Kanbak et al., 1996; Song et al., 1999) . However, this pathway may not be important for 3-aminophenol, because of the structural difficulty in formation of quinoneimine derivatives in this case. In rat renal slices, 4-aminophenol proved more toxic than 2-aminophenol, the authors drawing conclusions as to a rule for the position of the amino group for this kind of renal toxicity (Valentovic and Ball, 1998) . However, it remains to be elucidated whether oxidation-glutathione conjugation contributed to the cytotoxicity in renal slices. Based on our results, the renal toxicity of 3-aminophenol seems to be completely different from that of 4-aminophenol.
In conclusion, the susceptibility of the newborn rats to 3-aminophenol based on tremors, lowering of body weights and thyroid toxicity appears to be approx. 3 times higher than that of young rats, consistent with our previous results for two other chemicals, 4-nitrophenol and 2,4-dinitrophenol. The analytical results support the recommendation by the NRC (1993) that an additional uncertainty factor of 10 for the ADI is appropriate for infant safety in the absence of specific data for developmental toxicity.
